Our products

Please note that Immedica distributes the products mentioned only in designated geographical areas and that all products may not be available in all countries. Additionally, currently approved indications and presentations may differ between countries.

Ammonaps®
(sodium phenylbutyrate)
Urea Cycle Disorders

Links about Ammonaps:
European Medicines Agency (English)

Arlevert®
(cinnarizine / dimenhydrinate)
Vertigo of various origin

Links about Arlevert:
FASS för vårdgivare (Swedish)

GranuPAS®
(para-aminosalicylic acid)
Multi-Drug Resistant Tuberculosis

Links about GranuPAS:
European Medicines Agency (English)

Neofordex®
(dexamethasone)
Multiple myeloma

Links about Neofordex:
European Medicines Agency (English)

Orphacol®
(cholic acid)
Inborn errors of primary bile acid synthesis

Links about Orphacol:
European Medicines Agency (English)

Ravicti®
(glycerol phenylbutyrate)
Urea Cycle Disorders

Links about Ravicti:
European Medicines Agency (English)

Tepadina®
(thiotepa)
Haematopoetic Stem Cell Transplantation/solid tumors

Links about Tepadina:
European Medicines Agency (English)

Vertisan®
(betahistine dihydrochloride)
Vertigo of various origin

Links about Vertisan:
FASS för vårdgivare (Swedish)

Yondelis®
(trabectedin)
Soft Tissue Sarcoma and
Ovarian Cancer

Links about Yondelis:
European Medicines Agency (English)